Loading...
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
BACKGROUND: Outcomes in children and adolescents with recurrent or progressive high-grade glioma are poor, with a historical median overall survival of 5.6 months. Pediatric high-grade gliomas are largely immunologically silent or “cold,” with few tumor-infiltrating lymphocytes. Preclinically, pedia...
Na minha lista:
| Udgivet i: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8284840/ https://ncbi.nlm.nih.gov/pubmed/33838625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2024947 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|